๐ cemdisiran
Cemdisiran is an investigational RNA interference therapy developed by Alnylam Pharmaceuticals to reduce complement component C5 production for potential treatment of complement-mediated diseases.
1
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Seven-minute virtual reality intervention helps students tackle stress and exam anxiety | expired | Health | involved | 100% |